COMMUNIQUÉS West-GlobeNewswire

Pernix Therapeutics to Report Third Quarter 2018 Financial Results on Thursday, November 8
02/11/2018
MORRISTOWN, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, announced today that the Company will report financial results for the third [...]
Caladrius Biosciences to Host Third Quarter 2018 Financial Results Conference Call on Thursday, November 8, 2018 at 4:30 p.m. ET
02/11/2018
BASKING RIDGE, N.J., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Caladrius Biosciences, Inc. (Nasdaq: CLBS) (“Caladrius” or the “Company”), a clinical-stage biopharmaceutical company with multiple technology platforms targeting [...]
Catalyst Biosciences Announces Presentation at the 60th American Society of Hematology Annual Meeting & Exposition
02/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO), a clinical-stage biopharmaceutical company focused on developing novel medicines to address hematology [...]
Intensity Therapeutics Raises $6.5 Million in Series B Financing
02/11/2018
Proceeds to enable advancement of lead product candidate INT230-6 into Phase 2 clinical development for solid tumors WESTPORT, Conn., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Intensity Therapeutics, Inc. , a clinical-stage [...]
Neos Therapeutics to Host Third Quarter 2018 Financial Results Conference Call on November 9, 2018
02/11/2018
DALLAS and FORT WORTH, Texas, , Nov. 02, 2018 (GLOBE NEWSWIRE) -- Neos Therapeutics, Inc. (NASDAQ: NEOS) today announced that it will report third quarter 2018 financial results prior to the opening of U.S. financial [...]
Stemline Therapeutics Announces Four ELZONRIS Presentations, Including an Oral Presentation, at Upcoming ASH Meeting
02/11/2018
NEW YORK, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML), a biopharmaceutical company focused on the development and commercialization of novel oncology therapeutics, announced today that [...]
IMV Inc. Announces Q3 2018 Financial Results and Investor Conference Call Details
02/11/2018
Achieved Initial Positive Data from Phase 2 Clinical Trial in DLBCL with Merck Entered into Collaboration with Merck on Phase 2 Basket Trial Across Five Indications Attained Multiple Milestones in Clinical Trial With [...]
Myriad Presents Two New Studies at the Western Section of the American Urological Association
02/11/2018
New Data Demonstrate the Clinical Performance of the Prolaris ® and myRisk ® Hereditary Cancer Genetic Tests in Men with Prostate Cancer SALT LAKE CITY, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: [...]
Akcea Recognizes First Global Familial Chylomicronemia Syndrome (FCS) Awareness Day
02/11/2018
Community focuses on elevating awareness of the burden of FCS and impact on daily living BOSTON, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., [...]
Capricor Therapeutics to Provide Corporate Update at BIO-Europe Conference on Nov. 6
02/11/2018
Presentation to Focus on Company’s Therapeutic Pipeline for Duchenne Muscular Dystrophy and other Rare Diseases LOS ANGELES, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics, Inc . (NASDAQ: CAPR) will provide a [...]
Asterias Biotherapeutics to Report Third Quarter 2018 Results on November 12, 2018
02/11/2018
FREMONT, Calif., Nov. 02, 2018 (GLOBE NEWSWIRE) -- Asterias Biotherapeutics, Inc. (NYSE American: AST), a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated [...]
Aleafia Launches Global Expansion with Proposed Equity Stake in Australian Licensed Cannabis Company
02/11/2018
Aleafia to Distribute Medical Cannabis, Provide Technical Expertise to CannaPacific TORONTO, Nov. 02, 2018 (GLOBE NEWSWIRE) -- Aleafia Health Inc. (TSXV: ALEF: OTCQX: ALEAF, FRA: ARAH) (“ Aleafia “) and CannaPacific Pty [...]
111, Inc. Establishes Strategic Partnership with A. Menarini China Holding Co., Ltd
02/11/2018
SHANGHAI, China, Nov. 02, 2018 (GLOBE NEWSWIRE) -- 111, Inc. (NASDAQ: YI) ("111" or the "Company"), a leading integrated online and offline healthcare platform, today announced it has established a strategic partnership [...]
Digirad Corporation Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2018
02/11/2018
Discusses progress on new “HoldCo” strategy Announces sale of Telerhythmics business Approves a new Stock Buy Back Plan, replacing Dividends Reaffirms 2018 financial guidance for Revenue and Free Cash Flow and updates [...]
HMS Holdings Corp. Reports Third Quarter 2018 Results
02/11/2018
Record Quarterly Revenue of $154.3 Million Record Quarterly Commercial Revenue of $86.7 Million / YTD Commercial Revenue Up 24% Quarterly COB Revenue of $105.7 million / YTD COB Revenue Up 8% Full-Year 2018 Revenue [...]
Enzymatica AB: Enzymatica's rights issue is secured up to 100 percent
02/11/2018
Press release November 2, 2018 Enzymatica's rights issue is secured up to 100 percent Enzymatica announced on October 18, 2018 that the Board of Directors has decided to carry out a rights issue of a maximum of SEK 98.7 [...]
Curetis launches privately placed capital increase to raise up to €18.4 million
02/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR WITHIN THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO [...]
Rule 2.9 Announcement
02/11/2018
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 2 November 2018 [...]
OSE Immunotherapeutics Regains Worldwide Rights to its CD28 antagonist FR104 from Janssen Biotech
02/11/2018
OSE to pursue clinical development of FR104 to treat autoimmune diseases FR104’s good phase 1 clinical safety profile and first efficacy signal support phase 2 testing NANTES, France, Nov. 02, 2018 (GLOBE NEWSWIRE) -- [...]

Pages